Latest News and Events
Filter by
Selections
November 13, 2020
Arrowhead Presents New Clinical Data on Cardiometabolic Pipeline at AHA 2020
Read MoreNovember 13, 2020
Arrowhead Interim Clinical Data Demonstrate ARO-AAT Treatment Improved Multiple Biomarkers of Alpha-1 Liver Disease
Read MoreNovember 4, 2020
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3
Read MoreOctober 8, 2020
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
Read MoreSeptember 30, 2020
Arrowhead Pharmaceuticals to Participate in Upcoming Investor Conference
Read MoreSeptember 24, 2020